DroneShield's Trust Deficit: The Numbers Are Strong, But the Market's Doubts Run Deeper

DroneShield posts record H1 revenue but swings to loss; ASIC probe and short interest weigh on the stock.

There is a number that tells you more about DroneShield right now than any revenue figure or earnings projection: 15.7 percent. That is the share of the company's stock currently held in short positions, making the counter-drone specialist the most-shorted name on the entire Australian exchange. For a business that just posted record sales, that is a striking vote of no-confidence.

The skepticism is not without its reasons. DroneShield confirmed it continues to cooperate with the Australian Securities and Investments Commission over an investigation into market announcements and trading activity dating back to November 2025. Alongside that, the company disclosed a confidential settlement with a member of its management team — a payment it stressed was unrelated to termination, misconduct, or regular compensation. The fact that such a clarification was even necessary speaks to how finely balanced sentiment around the stock has become.

A Half-Year That Impresses on Paper

The operational picture, taken in isolation, is genuinely strong. First-half revenue for fiscal 2026 climbed 74 percent to a record A$125.8 million, while recurring software revenue surged 229 percent to A$11.5 million, supported by roughly 4,100 software-enabled devices in the field. The order book tells a similar story: secured revenue reached A$240.4 million as of August 21, up 36 percent year on year and already equivalent to 111 percent of total 2025 revenue. Of that, A$43 million is booked for 2027 and beyond.

The company also reaffirmed its full-year guidance of A$250 million to A$270 million in revenue. Yet beneath those headline numbers sits a less comfortable reality. The bottom line swung to a loss of A$32.2 million, against a profit of A$2.12 million in the prior-year half. Underlying EBITDA flipped to negative A$12.4 million from positive A$8.0 million, a deterioration the company attributes to lower gross margins and higher fixed costs as it scales production, sales, and service operations.

The Margin Question That Overhangs Everything

That margin compression is the crux of the debate. Revenue is no longer the metric investors are watching — the underlying EBITDA trajectory is. If gross margins stay under pressure while new costs keep landing, the loss could extend into the second half even if the company hits its revenue target. The bull case rests on the idea that recurring software revenue, which carries structurally higher margins than hardware sales, will gradually improve earnings quality. The planned RfRecon hardware ramp, with first deliveries targeted for the end of 2026, could broaden the revenue base further.

The balance sheet offers some breathing room. Cash and term deposits stood at A$180.0 million with no debt, down from A$210.6 million at the end of fiscal 2025. The drawdown reflects strategic investment in raw material inventories of A$85.0 million, partly to support the company's first European manufacturing line, which began production in June. That is a defensible use of capital for a company scaling up — but it also narrows the financial cushion if the ramp-up hits delays.

A Chart That Mirrors the Uncertainty

The market's verdict is visible in the share price. The stock trades at around €1.08, roughly 71 percent below its 52-week high of €3.79 reached on October 1, 2025, and sits about 40 percent below its 200-day moving average. Since the half-year results were released last Wednesday, the shares have slipped a further 1.8 percent — a muted reaction that itself suggests the market has already priced in much of the bad news.

Neither the RfRecon platform launch three weeks ago nor the lowered revenue guidance has shifted the trajectory. A Citigroup reporting threshold disclosure just over three weeks ago also failed to arrest the decline.

The Real Risk Isn't Operational

For investors, the uncomfortable truth is that the biggest overhang is not the margin trajectory or the pace of scaling — it is the unresolved regulatory question. An ongoing ASIC investigation weighs on institutional investors more heavily than any single quarterly figure, because it calls into question the reliability of the company's communication itself. The confidential personnel settlement, however benign the company insists it is, adds another layer of opacity.

The order book — A$240 million in secured revenue — suggests the underlying demand for counter-drone technology is real and growing. But until the ASIC probe concludes, that operational substance may not be enough to restore confidence. Investors in DroneShield are not just buying drone-defense technology; they are buying into an unresolved trust problem, and that risk is likely to shape the share price more than any individual growth metric in the near term. The next concrete test will be the start of RfRecon deliveries, targeted for late 2026 — and whether the underlying EBITDA figure finally starts moving in the right direction.